Sexual & Reproductive HealthCare
Volume 2, Issue 4 , Pages 137-142 , November 2011

Midwives at youth clinics attitude to HPV vaccination and their role in cervical cancer prevention

  • Marie G. Oscarsson

      Affiliations

    • School of Health and Caring Sciences, Linnaeus University, Sweden
    • Department of Public Health and Caring Sciences, Uppsala University, Sweden
    • Corresponding Author InformationCorresponding author at: School of Health and Caring Sciences, Faculty of Health, Social Work and Behavioural Sciences, Linnaeus University, SE-391 82 Kalmar, Sweden. Tel.: +46 480 44 60 80; fax: +46 480 44 69 55.
    • ,
  • Annica Dahlberg

      Affiliations

    • Department of Public Health and Caring Sciences, Uppsala University, Sweden
    • ,
  • Tanja Tydén

      Affiliations

    • Department of Public Health and Caring Sciences, Uppsala University, Sweden

Received 24 May 2011 ,Revised 11 August 2011 ,Accepted 23 September 2011.

References 

  1. Socialstyrelsen. Dödsorsaker 2005 [Causes of Death]. Stockholm: Socialstyrelsen; 2007.
  2. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100(9):622–629
  3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19
  4. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–998
  5. Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill. 2009;14(6):
  6. Raffle AE. Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ. 2007;335(7616):375–377
  7. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–114
  8. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Psychosocial aspects of vaccine acceptability. Vaccine. 2006;24(Suppl. 3):S201–S209[chapter 24]
  9. Kang HS, Moneyham L. Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students. Vaccine. 2010;28(3):811–816
  10. Tan J, Farrell L, Allen DG. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey. Aust NZ J Obstet Gynaecol. 2010;50(5):472–477
  11. Hopkins TG, Wood NJ, West RM, Darling JC. UK health professionals’ attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health. 2009;45(11):652–655
  12. Blomberg K, Forss A, Ternestedt BM, Tishelman C. From ‘silent’ to ‘heard’: professional mediation, manipulation and women’s experiences of their body after an abnormal Pap smear. Soc Sci Med. 2009;68(3):479–486
  13. Gottvall M, Larsson M, Hoglund AT, Tyden T. High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students. Eur J Contracept Reprod Health Care. 2009;14(6):399–405
  14. Levin BLB. Resultat från en kvalitativ undersökning med syfte att få kunskap om föräldrars, ungdomars och skolsköterskors inställning till HPV-vaccinering [results from a qualitative study aimed to gain knowledge of parents, youth and school nursers attitude to HPV vaccinatio] Stockholm: Kommunicera AB; 2007.
  15. Lehtinen M, Herrero R, Mayaud P, Barnabas R, Dillner J, Paavonen J, et al. Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries. Vaccine. 2006;24(Suppl. 3):[chapter 28], p. S3/233–241
  16. Dillner J. Cervical cancer screening in Sweden. Eur J Cancer. 2000;36(17):2255–2259
  17. Rodvall Y, Kemetli L, Tishelman C, Tornberg S. Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev. 2005;14(5):459–466
  18. Kvale S. Den kvalitativa forskningsintervjun. Lund: Studentlitteratur; 1997;
  19. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–112
  20. Oscarsson MG, Benzein EG, Wijma BE. The first pelvic examination. J Psychosom Obstet Gynaecol. 2007;28(1):7–12
  21. Paavonen J. At what age should we be vaccinating for human papillomavirus?. Gynecol Obstet Invest. 2010;70(4):233–236
  22. Brotherton JM, Leask J, Jackson C, McCaffery K, Trevena LJ. National survey of general practitioners’ experience of delivering the national human papillomavirus vaccination program. Sexual Health. 2010;7(3):291–298
  23. Tafuri S, Martinelli D, Vece MM, Quarto M, Germinario C, Prato R. Communication skills in HPV prevention: an audit among Italian healthcare workers. Vaccine. 2010;28(34):5609–5613
  24. Duval B, Gilca V, Boulianne N, Pielak K, Halperin B, Simpson MA, et al. Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions. J Adv Nurs. 2009;65(3):499–508
  25. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians’ attitudes and practices towards HPV vaccination. Acta Paediatr. 2008;97(11):1550–1556
  26. Sundstrom K, Tran TN, Lundholm C, Young C, Sparen P, Dahlstrom LA. Acceptability of HPV vaccination among young adults aged 18–30years – a population based survey in Sweden. Vaccine. 2010;28(47):7492–7500
  27. Oscarsson M, Anna-Karin H, Tanja T. The decision making process of HPV vaccination among young women; submitted for publication.
  28. Larsson M, Tyden T. Increased sexual risk taking behavior among Swedish female university students: repeated cross-sectional surveys. Acta Obstet Gynecol Scand. 2006;85(8):966–970
  29. Idestrom M, Milsom I, Andersson-Ellstrom A. Women’s experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand. 2003;82(8):756–761
  30. Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis. 2011;204(3):372–376

PII: S1877-5756(11)00032-2

doi: 10.1016/j.srhc.2011.09.001

Sexual & Reproductive HealthCare
Volume 2, Issue 4 , Pages 137-142 , November 2011

Article Tools